Indapamide and Dermatitis exfoliative - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative is reported as a side effect among people who take Indapamide (indapamide), especially for people who are female, 60+ old, also take Allopurinol, and have Gout.

The phase IV clinical study analyzes which people have Dermatitis exfoliative when taking Indapamide. It is created by eHealthMe based on reports of 21,640 people who have side effects when taking Indapamide from the FDA, and is updated regularly.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,152 Indapamide users. Check the latest studies of Indapamide.

What is Dermatitis exfoliative?

Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 688 drugs and 945 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative.

On Jul, 06, 2026

21,640 people reported to have side effects when taking Indapamide.
Among them, 29 people (0.13%) have Dermatitis exfoliative.

Could Indapamide cause Dermatitis exfoliative?

Among these 29 people:

What is the gender of people who have Dermatitis exfoliative when taking Indapamide? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Dermatitis exfoliative when taking Indapamide? *

What are other drugs people take besides Indapamide? *

What are other side effects people have besides Dermatitis exfoliative? *

Pruritus Generalised (generalized itching): 11 people, 37.93%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 11 people, 37.93%
Skin Exfoliation (removal of the oldest dead skin cells): 11 people, 37.93%
Wheezing (a high-pitched whistling sound made while you breath): 10 people, 34.48%
Drug Eruption (adverse drug reaction of the skin): 10 people, 34.48%
Parakeratosis: 10 people, 34.48%
Rash Erythematous (redness of the skin): 10 people, 34.48%
Lymphocytic Infiltration (lymphocyte deposition): 10 people, 34.48%
Fever: 4 people, 13.79%
Rashes (redness): 4 people, 13.79%

What are the existing conditions these people have? *

Nephrogenic Anaemia (anaemia due to kidney disease): 10 people, 34.48%
Gout (uric acid crystals building up in the body): 10 people, 34.48%
Fluid Overload (too much fluid in the blood): 5 people, 17.24%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.34%
Dyspnea (difficult or laboured breathing): 3 people, 10.34%
Rickets (softening of bones): 1 person, 3.45%
Rashes (redness): 1 person, 3.45%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 3.45%
Infection: 1 person, 3.45%
Gouty Arthritis (joint inflammation with crystal formation): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Indapamide and have Dermatitis exfoliative?

- Check whether Dermatitis exfoliative is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Indapamide:

Indapamide (22,152 reports)

Browse all side effects of Indapamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (688 drugs)

Browse all the conditions that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (945 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on indapamide (the active ingredients of Indapamide) and Indapamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.